Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-05-10
1990-07-10
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 82, C07D47106
Patent
active
049407155
ABSTRACT:
This invention provides novel 5H-pyrazolo[4,3-a]-quinolizin-5-one compounds which exhibit a selective inhibitory activity against IgE-antibody formation, and have utility for treatment of allergic diseases associated with IgE formation in mammals, such as allergic bronchial asthma, allergic rhinitis, atopic dermaties, hypersensitiveness, and the like.
REFERENCES:
patent: 3968119 (1976-07-01), Harnisch
patent: 4223032 (1980-09-01), Buckle et al.
patent: 4602014 (1986-07-01), Yokoyama
Kurashina Yoshikazu
Miyata Hiroshi
Momose Den-ichi
Kilby Scalzo Catherine S.
Kissei Pharmaceutical Co. Ltd.
Lee Mary C.
LandOfFree
5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therape does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therape, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therape will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1721098